checkAd

CureVac CTO Fotin-Mleczek Resigns

(PLX AI) – CureVac says Chief Technology Officer Mariola Fotin-Mleczek will resign from CureVac effective January 31, 2022. Mariola was responsible for the development and preclinical testing of CureVac's mRNA technology platform across the …

  • (PLX AI) – CureVac says Chief Technology Officer Mariola Fotin-Mleczek will resign from CureVac effective January 31, 2022.
  • Mariola was responsible for the development and preclinical testing of CureVac's mRNA technology platform across the therapeutic areas of prophylactic vaccines, oncology and molecular therapy
  • Further development of CureVac's unique mRNA technology platform will be led by Dr. Igor Splawski, Chief Scientific Officer of CureVac, and spearheaded by Dr. Patrick Baumhof, Senior Vice President Technology, who has a 15-year scientific tenure with the company
Der Analyst erwartet ein Kursziel von 18,65$, was einem Rückgang von +-0,44% zum aktuellen Kurs entspricht. Mit diesen Produkten können Sie die Kurserwartungen des Analysten übertreffen.
Übernehmen
Für Ihre Einstellungen haben wir keine weiteren passenden Produkte gefunden.
Bitte verändern Sie Kursziel, Zeitraum oder Emittent.
Alternativ können Sie auch unsere Derivate-Suchen verwenden
Knock-Out-Suche | Optionsschein-Suche | Zertifikate-Suche
WerbungDisclaimer
Wertpapier



0 Kommentare
Autor: PLX AI
 |  193   |   |   

Schreibe Deinen Kommentar

Disclaimer

CureVac CTO Fotin-Mleczek Resigns (PLX AI) – CureVac says Chief Technology Officer Mariola Fotin-Mleczek will resign from CureVac effective January 31, 2022. Mariola was responsible for the development and preclinical testing of CureVac's mRNA technology platform across the …

Nachrichten des Autors

Titel
Titel
Titel